European Pharmaceutical Review

SEPTEMBER 26, 2023

The European Commission (EC) has granted Sandoz the first marketing authorisation of biosimilar Tyruko ®* (natalizumab). Sandoz entered into a global commercialization agreement for biosimilar natalizumab with Polpharma Biologics in 2019. Sandoz has the rights to commercialise and distribute it in all markets under the deal.

Biosimilars 59

Biosimilars Dosage Packaging 59

Drug Patent Watch

JANUARY 7, 2025

They’re designed to be bioequivalent, meaning they have the same dosage, strength, route of administration, quality, and intended use as the original brand-name drug. “2021 Generic Drug & Biosimilars Access & Savings in the U.S. Food and Drug Administration. “Generic Drugs: Questions & Answers.”

Communication 85

Communication Dosage Drug Pricing Packaging 85

Express Pharma

NOVEMBER 26, 2024

Spanning pharma machinery, packaging, analytical instruments, laboratory technologies, ingredients, and beyond, it offers a comprehensive platform for stakeholders to engage in transformative dialogues and foster strategic partnerships. With exports nearing $27.84

Packaging 105

Packaging Biosimilars Pharmaceutical Manufacturing Dosage 105